Contrast-enhanced MR imaging of two superparamagnetic RES-contrast agents: functional assessment of experimental radiation-induced liver injury.
The purpose of this study was to compare liver contrast-enhancing characteristics of two superparamagnetic reticuloendothelial system (RES)-directed agents with different particle sizes, polycrystalline iron oxide nanocompounds (PION) and carboxydextran-coated maghemite (DDM128N/389, later referred to as DDM128), in an experimental model of focal radiation-induced hepatitis. PION, for the small particle size (31 nm), and DDM128, for the large particle size (59 nm), RES-directed agents were compared for liver enhancement after radiation-induced liver injury. A single x-irradiation exposure varying from 10 to 60 Gy was delivered to one side of the liver. T2-weighted spinecho magnetic resonance imaging was performed 3 days after x-irradiation at 30 minutes post-contrast. Using the RES-directed PION, the normal, non-irradiated portion of the liver decreased in signal intensity with a maximum negative enhancement of -66%, while the irradiated portion of the liver decreased in signal intensity by -24% (60 Gy). The signal intensity decline of irradiated liver tissue using PION was dose dependent, but was found at all radiation dose levels (10-60 Gy). The difference in signal intensity between irradiated (-63%) and non-irradiated (-82%) portions was also statistically different using DDM128 at 60 Gy. However, lower irradiation doses (10 and 30 Gy) failed to produce a statistically significantly different enhancement in the irradiated and non-irradiated portion of the liver. Sensitivity of liver enhancement with RES-directed agents is size dependent. The smaller particle (PION) is more sensitive for detection of radiation-induced hepatitis than the larger particle (DDM128). The relative insensitivity of DDM128 enhancement for diffuse liver injury will be clinically advantageous for detecting focal lesions in the presence of diffuse hepatic injury.
Department of Radiology, KH Lainz, Vienna, Austria.
M
M
Stiskal
F
F
Demsar
A
A
Mühler
H C
HC
Schwickert
T P
TP
Roberts
D
D
Szolar
H
H
Fischer
R C
RC
Brasch
D000818:Animals; D003287:Contrast Media; D005290:Ferric Compounds; D006520:Hepatitis, Animal / Q000209:etiology / Q000473:pathology*; D007089:Image Enhancement; D007501:Iron; D008099:Liver / Q000473:pathology* / Q000528:radiation effects; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D010087:Oxides; D010316:Particle Size; D011208:Powders; D011833:Radiation Injuries, Experimental / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley
D003287:Contrast Media; D005290:Ferric Compounds; D010087:Oxides; D011208:Powders; C094094:carboxydextran-coated magnetic iron oxide particles; C000499:ferric oxide; D007501:Iron